NanoString Technologies has named Alessandra Cesano its chief medical officer. Cesano brings more than 25 years of experience in drug development, diagnostics, and cancer immunology.
Cesano comes to NanoString from Cleave Biosciences where she served as CMO. She was also CMO and chief operations officer at Nodality. Prior to Nodality, she held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals, and positions in academia and tumor immunology research.
Cesano's credentials include an MD, a board certification in oncology, and a PhD in tumor immunology from the University of Turin. She is also a member of the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Hematology, the European Hematologic Association, and the Society for Immunotherapy of Cancer.